Aloisio dos Santos Almeida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aloisio dos Santos Almeida has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Abelardo Silva-Júnior
Laboratório de Pesquisas em Virologia e Imunologia ‐ LAPEVI, Instituto de Ciências Biológicas e da Saúde ‐ ICBS Universidade Federal de Alagoas Maceió Alagoas Brazil
1 shared publication - Anderson Brandão Leite
Laboratório Central de Saúde Pública de Alagoas (LACEN‐AL), Setor de Biologia Molecular e Vigilância Genômica Maceió Alagoas Brazil
1 shared publication - Camila Rose Bezerra de Lima
Laboratório Central de Saúde Pública de Alagoas (LACEN‐AL), Setor de Biologia Molecular e Vigilância Genômica Maceió Alagoas Brazil
1 shared publication - Hazerral de Oliveira Santos
Laboratório Central de Saúde Pública de Alagoas (LACEN‐AL), Setor de Biologia Molecular e Vigilância Genômica Maceió Alagoas Brazil
1 shared publication - Jean Phellipe Marques Do Nascimento
Institute of Biological and Health Sciences, Federal University of Alagoas (UFAL), Maceió, Alagoas, Brazil
1 shared publication - Magliones Carneiro de Lima
Laboratório Central de Saúde Pública de Alagoas (LACEN‐AL), Setor de Biologia Molecular e Vigilância Genômica Maceió Alagoas Brazil
1 shared publication
Latest Publications
- 24 June 2026
- Published by Wiley in Tropical Medicine & International Health
- Vol. 31 (10) , 1419-1432
Genomic Surveillance of Dengue Virus During the 2024 Outbreak in a Northeastern Brazilian State
Dengue remains a major public health challenge in tropical regions, where viral genetic diversity, vector ecology and human mobility contribute to recurrent outbreaks. In 2024, Brazil experienced its largest recorded dengue epidemic, with intense transmission across the Northeast region. This study characterizes the epidemiological, genomic and phylogeographic features of dengue virus (DENV) circulation during the 2024 outbreak in Alagoas, northeastern Brazil. Of 6102 suspected cases analysed by molecular diagnostics, 1607 (26.3%) were confirmed as DENV infections. Epidemiological analyses revealed widespread transmission across 79 municipalities, marked seasonality with peak incidence between March and August, and a disproportionate burden among adolescents and young adults. DENV‐1 and DENV‐2 were the predominant serotypes, accounting for 57.1% and 42.6% of confirmed cases, respectively; three DENV‐3 infections and one DENV‐1/DENV‐2 co‐infection were also identified. Whole‐genome sequencing yielded high‐quality genomic data supporting phylogenetic and phylogeographic analyses. DENV‐1 sequences belonged to genotype V, classified into lineages E.1 and D.1.1, while DENV‐2 sequences clustered within genotype II (lineage F.1.1.2) and genotype III (lineage C.1.1). Time‐scaled phylogenetic analyses revealed multiple independent introductions of both serotypes from distinct Brazilian regions, followed by sustained local transmission and lineage expansion. Infections among non‐residents, including an international case, further underscore the role of population mobility in viral dissemination. Collectively, these findings indicate that the 2024 outbreak was driven by recurrent viral introductions combined with the persistence of locally established transmission chains, highlighting the value of integrated genomic surveillance for outbreak preparedness and public health response.
- 24 June 2026
- Published by Wiley in Tropical Medicine & International Health
- Vol. 31 (10) , 1419-1432
Genomic Surveillance of Dengue Virus During the 2024 Outbreak in a Northeastern Brazilian State
Dengue remains a major public health challenge in tropical regions, where viral genetic diversity, vector ecology and human mobility contribute to recurrent outbreaks. In 2024, Brazil experienced its largest recorded dengue epidemic, with intense transmission across the Northeast region. This study characterizes the epidemiological, genomic and phylogeographic features of dengue virus (DENV) circulation during the 2024 outbreak in Alagoas, northeastern Brazil. Of 6102 suspected cases analysed by molecular diagnostics, 1607 (26.3%) were confirmed as DENV infections. Epidemiological analyses revealed widespread transmission across 79 municipalities, marked seasonality with peak incidence between March and August, and a disproportionate burden among adolescents and young adults. DENV‐1 and DENV‐2 were the predominant serotypes, accounting for 57.1% and 42.6% of confirmed cases, respectively; three DENV‐3 infections and one DENV‐1/DENV‐2 co‐infection were also identified. Whole‐genome sequencing yielded high‐quality genomic data supporting phylogenetic and phylogeographic analyses. DENV‐1 sequences belonged to genotype V, classified into lineages E.1 and D.1.1, while DENV‐2 sequences clustered within genotype II (lineage F.1.1.2) and genotype III (lineage C.1.1). Time‐scaled phylogenetic analyses revealed multiple independent introductions of both serotypes from distinct Brazilian regions, followed by sustained local transmission and lineage expansion. Infections among non‐residents, including an international case, further underscore the role of population mobility in viral dissemination. Collectively, these findings indicate that the 2024 outbreak was driven by recurrent viral introductions combined with the persistence of locally established transmission chains, highlighting the value of integrated genomic surveillance for outbreak preparedness and public health response.